Fortis, TotipotentRX collaborate

Wednesday, March 16, 2011 12:48 PM

New Delhi, India-based Fortis Healthcare is collaborating with U.S.-based TotipotentRX Cell Therapy to set up stem cell therapy centers across its hospitals, according to BIO SmartBrief.

The centers will offer cellular therapies and will undertake stem cell clinical research procedures relating to diabetes, cancer, cardiovascular disease and neurological ischemia, Fortis Healthcare said.

"This allows Fortis to partner with the finest in the field of stem cell therapy and lead the way in this specialized new treatment modality, acknowledged to be at the cutting edge of modern medicine," said Shivinder Mohan Singh, Fortis Healthcare’s managing director.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs